An in vivo system in man for quantitation of estrogenicity. II. Pharmacologic changes in binding capacity of serum corticosteroid-binding globulin induced by conjugated estrogens, mestranol, and ethinyl estradiol.
D003280:Contraceptives, Oral, Synthetic / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004966:Estrogens, Conjugated (USP) / Q000494:pharmacology*; D004997:Ethinyl Estradiol / Q000494:pharmacology*; D005260:Female; D006801:Humans; D008593:Menopause; D008656:Mestranol / Q000494:pharmacology*; D009640:Norethindrone / Q000494:pharmacology; D009644:Norgestrel / Q000494:pharmacology; D011247:Pregnancy; D014156:Transcortin / Q000378:metabolism*
D003280:Contraceptives, Oral, Synthetic; D004966:Estrogens, Conjugated (USP); D009644:Norgestrel; D004997:Ethinyl Estradiol; D014156:Transcortin; D008656:Mestranol; D009640:Norethindrone